Remove the Needle Ensure '0' is displayed before removing the needle
Include healthy fats
Microdosing uses doses and schedules that differ from FDA-approved labeling and is considered an off-label approach
What about quality and safety - embedded in a licensed product
We excluded patients with cirrhotic liver, history of gall bladder, biliary disorders, pancreatic diseases, interrupted use of GLP-1RAs throughout the study period, and patients used other drugs with potential effects on the motility of biliary tracts such as cholecystokinin, motilin hormone, cholinomimetic agents like prostigmine, erythromycin, cisapride, cholystyramine, intravenous aminoacids, cholinergic agents like atropine, somatostatin, and progesterone, trimebutine, loperamide and ondansetron